Anuh Pharma surged on Thursday after it received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of company's Erythromycin products.

The company's products include Erythromycin Estolate, Erythromycin Ethyl Succinate and Erythromycin Stearate.

Shares of the company are trading at Rs 156, up Rs 4.2, or 2.77% at the Bombay Stock Exchange (BSE) on Thursday at 12:52 p.m.

The scrip has touched an intra-day high of Rs 165 and low of Rs 151.40. The total volume of shares traded at the BSE is 19,766.

In the earlier session, the shares declined 0.91%, or Rs 1.4, at Rs 151.80. Currently, the stock is trading down 7.58% from its 52-week high of Rs 168.80 and above 48.57% over the 52-week low of Rs 105.